Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
about
Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cellsThe therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumorsHigh expression of class III β-tubulin predicts good response to neoadjuvant taxane and doxorubicin/cyclophosphamide-based chemotherapy in estrogen receptor-negative breast cancerDual regulation of cytoplasmic and mitochondrial acetyl-CoA utilization for improved isoprene production in Saccharomyces cerevisiae.Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplificationUnliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpointThe potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cellsAbcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment responseProinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism.Lactogens and estrogens in breast cancer chemoresistance.Withaferin a suppresses estrogen receptor-α expression in human breast cancer cellsA molecular analysis provides novel insights into androgen receptor signalling in breast cancer.PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype.Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36)DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells.A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.Reversal effects of Raloxifene on paclitaxel resistance in 2 MDR breast cancer cells.Different administration strategies with paclitaxel induce distinct phenotypes of multidrug resistance in breast cancer cellsMicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.Vernonia amygdalina: anticancer activity, authentication, and adulteration detection.Fractionated irradiation-induced EMT-like phenotype conferred radioresistance in esophageal squamous cell carcinoma.Ixabepilone: a new microtubule-targeting agent for breast cancer.ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.Inhibition of ERα/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabineDiallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells.LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expressionEndocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies.Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death.Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.A preliminary study of 18F-FES PET/CT in predicting metastatic breast cancer in patients receiving docetaxel or fulvestrant with docetaxel
P2860
Q24304751-D482668B-0517-4774-BC4C-CDA36BDDA607Q24596235-6AB5EEC2-2AED-4141-A23E-3E22060AF670Q26829978-C0C8E499-2983-411F-8C0A-5F06C1161E55Q27851983-85AE2DF2-CECA-426C-BB67-2704239587A4Q28598377-AE4495FB-85ED-4AE8-92ED-B12238E01043Q28820752-6855CA52-EA4B-43AB-A026-F222034CD4C9Q30560953-30FA8C92-6A75-4436-83CE-7026FC776868Q33480671-82CC8666-EE8D-4819-8ECD-879A45EACA66Q34048154-AE7F977A-C135-455C-AC7D-2A496EB7EC1FQ34051930-F16124F6-3A31-4605-850A-5203C377DFFAQ34181200-E2C2CC9F-50A9-4C46-AB9D-C9D360BAFCB1Q34976544-785CAA77-6918-4B03-BF9D-F5649D1BB853Q35075176-2751C42B-1708-4663-BB7D-2B02EEBCDAC1Q35085709-C4BD5544-7BFC-4EC6-BD6F-8BF3F5951B3CQ35189443-03838060-3EF6-4E12-85E5-2F88764CA553Q35690099-3F03ED4C-DACB-4BE7-90EC-1DF255E2D76CQ35742509-C81177BD-4083-448C-AC6B-C1D090CA1E8BQ35802058-F6028C6D-F55F-40F0-BF0C-8EFD537F3485Q35835922-1DA26C0D-B19D-4ACB-91FE-4107AAC85EBAQ36326466-1CF25C92-52F7-4561-AF24-21AAE3B6E0F1Q36603339-DC252734-B338-41F1-8386-534DFE111FD5Q36843815-1003C21B-C8E2-428C-9BFC-20523078566FQ36893304-83FBEAA4-E56E-4139-BD90-22E13F012B39Q36905747-B8B4DAB3-2D83-4549-9CD2-982B763E09DCQ36977938-4872A39E-12B6-48BD-9C26-200DC89BEABCQ37152198-44BEE2D5-C830-4564-B6E4-D670AFA0910FQ37159488-B876F80B-2B93-4B29-8964-7333CF7E9B10Q37190494-8A9B0B93-C16C-42F7-A9A4-EB71BB8644F8Q37324446-EF14E33B-2B60-4DAB-9C09-89AAE0DED302Q37565516-1975BFAB-E794-483E-B422-97A2406B6DE7Q37615049-BA49AE0A-2193-48F6-82F8-D07A4236A08AQ37697180-C1172F26-9E0E-4554-8F75-5E537F51E1E9Q37707677-C3B663D3-218A-4DA8-9261-53D7CAF05B89Q38573685-44A671F3-26A5-48AB-8B65-EC86B9833DF3Q38833708-347BDBF7-21F9-4057-BB2C-338EAE42A45FQ39071807-6941E7D6-8FE3-45EE-B45F-52E886246EF6Q39207391-14184502-3A1A-4B35-ABB5-C972D8DF3F87Q39388525-8F3DD151-67BF-47FD-BBA4-0B10C2391C38Q39430827-822D39A2-E1A6-45D2-A0AE-63BB574D1B20Q41140406-56A11CE5-F040-439D-AE37-AAFD78506B19
P2860
Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Estrogen receptor alpha mediat ...... ition of apoptotic cell death.
@en
type
label
Estrogen receptor alpha mediat ...... ition of apoptotic cell death.
@en
prefLabel
Estrogen receptor alpha mediat ...... ition of apoptotic cell death.
@en
P2093
P1433
P1476
Estrogen receptor alpha mediat ...... ition of apoptotic cell death.
@en
P2093
Ben Ho Park
Meihua Sui
Nancy E Davidson
Weimin Fan
P304
P356
10.1158/0008-5472.CAN-06-4582
P407
P577
2007-06-01T00:00:00Z